John Ochsner Endowed Professor of Surgery, Section of Vascular/Endovascular Surgery
Ochsner Clinic
Program Director, Vascular Surgery Fellowship
Ochsner Clinic
New Orleans, Louisiana
Presenter
SESSION 11: MORE ABOUT CAROTID DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
Presenter
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
Moderator
SESSION 3: Lower Extremity Arterial – Part I
SESSION 11: MORE ABOUT CAROTID DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
How Should Acute Stroke Severity (NIHSS) Influence Timing To Therapeutic Intervention: For TPA Use; For CEA And CAS; For Intracranial Arterial Clot Removal: It Matters To Neurologic Outcomes
10:16 AM - 10:21 AM
Presenter
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
When Is Urgent (Within 48 Hours) CEA Or CAS Fairly Indicated After A Stroke: How Does Use Of tPA Influence Indications And Neurologic Outcomes In This Setting
11:36 AM - 11:41 AM
Moderator
SESSION 3: Lower Extremity Arterial – Part I